comunicacio

AELAM donates 21.000€ to research on lymphangioleiomyomatosis

Leave a Comment / Breast cancer, Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

A representation from AELAM (Spanish Association of Lymphangioleiomyomatosis) delivered a donation of 21.000€ for the research on this disease. This collaboration will be used, among others, to develop a screening project for new therapeutic strategies for lymphangioleiomyomatosis (LAM). The act of delivery took place in the Duran i Reynals Hospital and counted on the attendance of the Bellvitge Institute of […]

AELAM donates 21.000€ to research on lymphangioleiomyomatosis Read More »

IDIBELL receives more than one and a half million euros from AECC to fund cancer research projects

Leave a Comment / Cancer, Cancer Immunotherapy , Cancer Metabolism, Colorectal Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Nutrition and Cancer, Psycho-oncology and Digital Health (PSODIG), Resistance and Progression Mechanisms in Prostate Cancer, TGF-beta and cancer, Tumour Angiogenesis / By

The Spanish Association Against Cancer (AECC) distributes every year a large amount of financial aid for cancer research with the ultimate goal of bringing scientific results closer to patients, which would result in an improvement in early detection of cases and their quality of life and an increase in their survival. At IDIBELL, cancer is

IDIBELL receives more than one and a half million euros from AECC to fund cancer research projects Read More »

Sinergia 2021: the return of live science activities and release of new audiovisual content

Leave a Comment / Outreach and education / By

The third edition of the L’Hospitalet health research and innovation festival will be held from 15 to 20 November, coinciding with the 26th Science Week. Live activities will take place at the Duran i Reynals Hospital and the Harmonia building in L’Hospitalet.

Sinergia 2021: the return of live science activities and release of new audiovisual content Read More »

A new stent improves the treatment of coronary heart disease in people with diabetes

Leave a Comment / Cardiovascular Diseases Research Group (BIO-HEART), Cardiovascular, Respiratory and Systemic Diseases and cellular aging Program, Translational Medicine Area / By

Its greater effectiveness has been verified in a study coordinated by the Bellvitge Hospital and IDIBELL. The new device reduces the number of serious complications by 35% one year after the intervention. The study was published in the world’s leading cardiovascular journal.

A new stent improves the treatment of coronary heart disease in people with diabetes Read More »

The study of genetic variants for the early detection of colorectal cancer: current state and future perspectives

Leave a Comment / Cancer, Colorectal Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

An IDIBELL and ICO study determines that the set of genetic variants has an important role in the evolution of colorectal cancer. However, it is still too soon to use them as the single tool for screening and early detection of colorectal cancer.

The study of genetic variants for the early detection of colorectal cancer: current state and future perspectives Read More »

Identification of a new mitochondrial syndrome characterized by multisystemic involvement

Leave a Comment / Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

“The genetic identification of this new disease will facilitate a faster diagnosis in the future, which will allow offering precise genetic counseling and clinical management,” highlights Aurora Pujol.

Identification of a new mitochondrial syndrome characterized by multisystemic involvement Read More »

Described new predictors of mortality in severe pulmonary embolism

Leave a Comment / Bellvitge translational imaging biomarkers group (TRIBIO), Cardiovascular, Respiratory and Systemic Diseases and cellular aging Program, Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention Program, Neurologic Diseases and Neurogenetics , Neuroscience Area, Neuroscience Program, Pneumology , Translational Medicine Area / By

A study carried out by researchers from IDIBELL and the Bellvitge University Hospital has described new predictors of mortality in the endovascular treatment of severe pulmonary embolism.

Described new predictors of mortality in severe pulmonary embolism Read More »

Breast cancer cells create collagen shields to protect themselves from the immune system

Leave a Comment / Breast cancer, Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

A study published in Nature with the participation of IDIBELL and ICO shows that a protein on the surface of mammary tumor cells binds to extracellular collagen and aligns it to block the entry of immune cells.

Breast cancer cells create collagen shields to protect themselves from the immune system Read More »

Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery

Leave a Comment / Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention Program, Hepato-biliary-pancreatic pathology , Translational Medicine Area / By

Dr. Joan Fabregat Prous, a principal investigator of the IDIBELL hepato-biliary-pancreatic pathology research group and head of the section of the General and Digestive Surgery Service of the Bellvitge University Hospital, received the “Pere Virgili Award” on October 14th. The event took place at the Royal Academy of Medicine of Catalonia.

Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery Read More »

Scroll to Top